Lance Buterbaugh v. HHS - Tdap, Guillain-Barré Syndrome (2016)

Lance Buterbaugh filed a petition for compensation on February 12, 2014, alleging that the Tetanus-diphteria-acellular Pertussis (Tdap) vaccine, received on February 23, 2012, caused him to suffer Guillain-Barré Syndrome (GBS). The Tdap vaccine is listed on the Vaccine Injury Table.

Mr. Buterbaugh further alleged that he suffered residual effects from this injury for more than six months.

The respondent, the Secretary of Health and Human Services, denied that the Tdap vaccine caused Mr. Buterbaugh's GBS or any other injury.

Despite the denial, the parties reached a joint stipulation for compensation. The stipulation was found reasonable by Special Master Christian J.

Moran. Mr.

Buterbaugh was awarded a lump sum payment of $165,000.00, representing compensation for all damages available under the program. The decision directed that judgment be entered according to the stipulation.

Petitioner counsel was Ronald Homer of Conway, Homer & Chin-Caplan, P.C., and respondent counsel was Linda Renzi of the U.S. Department of Justice.

The public decision does not describe the specific onset of symptoms, medical tests, treatments, or expert witnesses.